Potential of the signature index (S-index), a diffusion MRI Biomarker, to enhance diagnosis of clinically significant prostate cancer and decrease the rate of unnecessary biopsies
The S-index and other diffusion MRI biomarkers demonstrate strong performance for the classification of clinically significant prostate cancer and may represent an important step toward enhancing the clinical value of MRI for improving prostate cancer management.
Authors
- Pornphan Wibulpolprasert (ORCID: https://orcid.org/0000-0003-0895-5111)
- Kittinut Kijvikai
- Sith Phongkitkarun (ORCID: https://orcid.org/0000-0002-1578-2784)
- Suchin Worawichawong (ORCID: https://orcid.org/0000-0003-1238-1536)
- Pattarasuda Leelarujijaroen
- Adun Kampaengtip (ORCID: https://orcid.org/0000-0002-7293-2320)
- Denis Le Bihan
Institutions
- Mahidol University (TH)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Université Paris-Saclay (FR)
- CEA Paris-Saclay - Etablissement de Saclay (FR)
- CEA Paris-Saclay (FR)
- Ramathibodi Hospital (TH)
Publication Details
- Journal
- European Journal of Radiology
- Published
- 2026-03-14
- DOI
- https://doi.org/10.1016/j.ejrad.2026.112788
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00